BrightSpring Health Services, Inc. (NASDAQ: BTSG) announced its financial results for the third quarter of 2025 during a conference call on October 28, 2025. The call...
Edesa Biotech, Inc. announced significant findings from its Phase 3 clinical trial of paridiprubart (EB05), a promising treatment for Acute Respiratory Distress Syndrome (ARDS), which was...
Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company based in Toronto, has reported promising results from its Phase 3 clinical trial for the drug candidate...
Victory Capital Holdings, Inc. (VCTR) has been upgraded to a buy rating following a significant surge in assets under management and a major acquisition involving Amundi...
Toll Brothers, Inc. has demonstrated remarkable resilience in a challenging housing market, maintaining a strong revenue growth trajectory despite economic headwinds. The company’s strategic pricing and...
Halozyme Therapeutics has taken a significant step in enhancing its drug delivery capabilities by announcing the acquisition of Elektrofi, Inc. for an upfront payment of $750...
Forgent Power Solutions, Inc. has officially opened a new manufacturing facility in Dayton, Minnesota, adding an impressive 500,000 square feet to its operational capacity. This expansion...
The average short interest in the S&P 500 Healthcare sector decreased in August 2023, indicating a slight easing of negative investor sentiment. According to recent data,...
The Schwab U.S. Large-Cap ETF, known by its ticker symbol SCHX, has received a rating upgrade to “buy” as market dynamics shift, creating a more balanced...
